ENOVEnovis Corporation
22.18USD-2.10%Mkt Cap: 1.27B USDP/E: Last update: 2026-06-01

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconst…

Indicators:|

Key Statistics

Company
Market Cap1.27B USD
Enterprise Value2.69B USD
Revenue (TTM)2.28B USD
Gross Profit1.35B USD
Net Income (TTM)-1.18B USD
Revenue/Share39.83 USD
Last Price22.18 USD
Fiscal Year EndDec 2025
MR QuarterApr 2026
Employees7.8K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)5.58
PEG3.45
EV/EBITDA7.21
EV/Revenue1.18
P/S0.57
P/B0.88
EPS (TTM)-19.89
EPS (Forward)4.06
52W Range
21.007% of range36.82
52W High36.82 USD
52W Low21.00 USD
Profitability
Gross Margin59.84%
Oper. Margin3.64%
EBITDA Margin16.34%
Profit Margin-52.69%
ROE-79.51%
ROA-30.89%
Growth
Revenue Growth5.40%
Earnings Growth
Cash Flow & Leverage
Operating CF217.29M USD
CapEx (TTM)197.38M USD
FCF Margin9.08%
FCF Yield16.26%
Net Debt1.38B USD
Net Debt/EBITDA3.70
Balance Sheet
Debt/Equity0.93
Current Ratio2.04
Quick Ratio0.78
Book Value/Sh25.66 USD
Cash/Share0.5760 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split581:1000
Split DateApr 5, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)43.00 USD
Target Range33.00 USD55.00 USD
# Analysts11
Ownership
Shares Out.57.56M
Float56.59M
Insiders1.61%
Institutions119.66%
Short Interest
Short Ratio7.5d
Short % Float17.41%
Short % Out.14.60%
Shares Short8.40M
Short (prev mo.)8.58M
Technical
SMA 5024.04 (-7.7%)
SMA 20026.94 (-17.7%)
Beta1.52
S&P 52W Chg27.70%
Avg Vol (30d)1.02M
Avg Vol (10d)1.10M
Technical Indicators
RSI (14)41.9
MACD-0.2451
MACD Signal0.1217
MACD Hist.-0.3668
BB Upper27.45 USD
BB Middle24.78 USD
BB Lower22.12 USD
BB Width21.52%
ATR (14)1.348 USD
Vol Ratio (20d)0.24x